US 3936026A
· Hampel et al.
· 1976
[cited by applicant]
US 4351327A
· Rinne
· 1982
[cited by applicant]
US 4782832A
· Trimble et al.
· 1988
[cited by applicant]
US 4944310A
· Sullivan
· 1990
[cited by applicant]
US 5287898A
· Falb et al.
· 1994
[cited by applicant]
US 5558084A
· Daniell
· 1996
[cited by applicant]
US 5564415A
· Dobson
· 1996
[cited by applicant]
US 5607316A
· Ishikawa
· 1997
[cited by applicant]
US 5916493A
· Miller
· 1999
[cited by applicant]
US 5943473A
· Levine
· 1999
[cited by applicant]
US 6135432A
· Hebblewhite
· 2000
[cited by applicant]
US 6216691B1
· Kenyon et al.
· 2001
[cited by applicant]
US 6397841B1
· Kenyon
· 2002
[cited by applicant]
US 6398197B1
· Dickinson
· 2002
[cited by applicant]
US 6532959B1
· Berthon-Jones
· 2003
[cited by applicant]
US 6554260B1
· Lipscombe
· 2003
[cited by applicant]
US 6581594B1
· Drew et al.
· 2003
[cited by applicant]
US 6690924B1
· Jan et al.
· 2004
[cited by applicant]
US 6935337B2
· Virr
· 2005
[cited by applicant]
US 7096864B1
· Mayer
· 2006
[cited by applicant]
US 7111624B2
· Thudor et al.
· 2006
[cited by applicant]
US 7137388B2
· Virr
· 2006
[cited by applicant]
US 7157035B2
· Edirisuriya et al.
· 2007
[cited by applicant]
US 7393222B2
· Asakura
· 2008
[cited by applicant]
US 7413173B2
· DiMatteo et al.
· 2008
[cited by applicant]
US 7439929B2
· Ozkar
· 2008
[cited by applicant]
US 7478635B2
· Wixey et al.
· 2009
[cited by applicant]
US 7677246B2
· Kepler et al.
· 2010
[cited by applicant]
US 7866944B2
· Kenyon et al.
· 2011
[cited by applicant]
US 7942824B1
· Kayyali et al.
· 2011
[cited by applicant]
US 8397719B2
· Kepler et al.
· 2013
[cited by applicant]
US 8544465B2
· Smith et al.
· 2013
[cited by applicant]
US 8545416B1
· Kayyali et al.
· 2013
[cited by applicant]
US 8636479B2
· Kenyon et al.
· 2014
[cited by applicant]
US 8638014B2
· Sears et al.
· 2014
[cited by applicant]
US 8677993B2
· Cortez, Jr. et al.
· 2014
[cited by applicant]
US 9512856B2
· Nibu et al.
· 2016
[cited by applicant]
US 20020014240A1
· Truschel
· 2002
[cited by applicant]
US 20040017318A1
· Annabi et al.
· 2004
[cited by applicant]
US 20060266365A1
· Stallard
· 2006
[cited by applicant]
US 20070068526A1
· Lang et al.
· 2007
[cited by applicant]
US 20080035145A1
· Adams et al.
· 2008
[cited by applicant]
US 20080276939A1
· Tiedje
· 2008
[cited by applicant]
US 20090007912A1
· Lindell et al.
· 2009
[cited by applicant]
US 20090099505A1
· Hendrixson et al.
· 2009
[cited by applicant]
US 20090156952A1
· Hunter et al.
· 2009
[cited by applicant]
US 20110132360A1
· Feldhahn et al.
· 2011
[cited by applicant]
US 20110271956A2
· Smith et al.
· 2011
[cited by applicant]
US 20110309992A1
· Ali
· 2011
[cited by applicant]
US 20120240932A1
· Gusky et al.
· 2012
[cited by applicant]
US 20130310713A1
· Weber et al.
· 2013
[cited by applicant]
US 20160310691A1
· Bath et al.
· 2016
[cited by applicant]
US 20180369521A1
· Velzy et al.
· 2018
[cited by applicant]
CN 2327396
· 1999
[cited by applicant]
CN 1691437
· 2005
[cited by applicant]
CN 1805766A
· 2006
[cited by applicant]
CN 1809397A
· 2006
[cited by applicant]
CN 1829549A
· 2006
[cited by applicant]
CN 101024105A
· 2007
[cited by applicant]
CN 101052985A
· 2007
[cited by applicant]
CN 201042552Y
· 2008
[cited by applicant]
CN 101296721A
· 2008
[cited by applicant]
CN 101365509A
· 2009
[cited by applicant]
CN 101541367A
· 2009
[cited by applicant]
CN 201775525U
· 2011
[cited by applicant]
CN 201823138
· 2011
[cited by applicant]
CN 102105189A
· 2011
[cited by applicant]
CN 102133447A
· 2011
[cited by applicant]
CN 102170932A
· 2011
[cited by applicant]
CN 102481431A
· 2012
[cited by applicant]
CN 102596299A
· 2012
[cited by applicant]
CN 102686282A
· 2012
[cited by applicant]
CN 102725015A
· 2012
[cited by applicant]
CN 103055400A
· 2013
[cited by applicant]
CN 103124575A
· 2013
[cited by applicant]
CN 103143092A
· 2013
[cited by applicant]
CN 203183455
· 2013
[cited by applicant]
CN 103384541A
· 2013
[cited by applicant]
CN 105307715A
· 2016
[cited by applicant]
DE 29909611U1
· 1999
[cited by applicant]
EP 1127583A2
· 2001
[cited by applicant]
EP 1369141A1
· 2003
[cited by applicant]
EP 1898337A1
· 2008
[cited by applicant]
EP 1900387A1
· 2008
[cited by applicant]
EP 2245985A1
· 2010
[cited by applicant]
EP 2317150A1
· 2011
[cited by applicant]
EP 2471568A2
· 2012
[cited by applicant]
EP 2572747A1
· 2013
[cited by applicant]
EP 2703034A2
· 2014
[cited by applicant]
FR 2579896A1
· 1986
[cited by applicant]
GB 1364127A
· 1974
[cited by applicant]
JP H03213293
· 1991
[cited by applicant]
JP 819611A
· 1996
[cited by applicant]
JP 2001274719
· 2001
[cited by applicant]
JP 2003065567A
· 2003
[cited by applicant]
JP 200527217
· 2005
[cited by applicant]
JP 2005198702A
· 2005
[cited by applicant]
JP 2006109534A
· 2006
[cited by applicant]
JP 2009508647
· 2009
[cited by applicant]
JP 2009511218A
· 2009
[cited by applicant]
JP 2010501315A
· 2010
[cited by applicant]
JP 2011005240
· 2011
[cited by applicant]
JP 2011512889A
· 2011
[cited by applicant]
JP 2011525833A
· 2011
[cited by applicant]
JP 2013018017A
· 2013
[cited by applicant]
JP 2013509219A
· 2013
[cited by applicant]
JP 2014524268A
· 2014
[cited by applicant]
JP 2015509427A
· 2015
[cited by applicant]
JP 2021100646
· 2021
[cited by applicant]
TW 432746
· 2001
[cited by applicant]
TW 200711671A
· 2007
[cited by applicant]
WO WO1998004310
· 1998
[cited by applicant]
WO WO1998034665
· 1998
[cited by applicant]
WO WO2000078381
· 2000
[cited by applicant]
WO 02066107A1
· 2002
[cited by applicant]
WO WO02078775A2
· 2002
[cited by applicant]
WO 03043560A2
· 2003
[cited by applicant]
WO WO2004073778
· 2004
[cited by applicant]
WO 2005063323A1
· 2005
[cited by applicant]
WO WO2005063328
· 2005
[cited by applicant]
WO 2006045602A1
· 2006
[cited by applicant]
WO WO2006074513
· 2006
[cited by applicant]
WO WO2006138331A1
· 2006
[cited by applicant]
WO WO2006130903
· 2006
[cited by applicant]
WO 2007019625A1
· 2007
[cited by applicant]
WO 2007019627A1
· 2007
[cited by applicant]
WO 2007038152
· 2007
[cited by applicant]
WO 2007045017A2
· 2007
[cited by applicant]
WO WO2007038152A2
· 2007
[cited by applicant]
WO WO2007051230A1
· 2007
[cited by applicant]
WO 2008024001A1
· 2008
[cited by applicant]
WO 2008098382A1
· 2008
[cited by applicant]
WO 2008100983A2
· 2008
[cited by applicant]
WO 2009011907A1
· 2009
[cited by applicant]
WO WO2009052560
· 2009
[cited by applicant]
WO 2009156921A1
· 2009
[cited by applicant]
WO WO2010031126A1
· 2010
[cited by applicant]
WO 2010036635A1
· 2010
[cited by applicant]
WO 2010140903A1
· 2010
[cited by applicant]
WO WO2010135785
· 2010
[cited by applicant]
WO WO2011056080
· 2011
[cited by applicant]
WO WO2011122964A1
· 2011
[cited by applicant]
WO WO2011149362A1
· 2011
[cited by applicant]
WO 2012095764A1
· 2012
[cited by applicant]
WO 2012135912
· 2012
[cited by applicant]
WO WO2012154064A2
· 2012
[cited by applicant]
WO WO2012160477
· 2012
[cited by applicant]
WO WO2012171072
· 2012
[cited by applicant]
WO 2013002650
· 2013
[cited by applicant]
WO 2013002650A1
· 2013
[cited by applicant]
WO WO2013020167
· 2013
[cited by applicant]
WO 2013133889A1
· 2013
[cited by applicant]
WO 2013135318A1
· 2013
[cited by applicant]
WO 2013137753A1
· 2013
[cited by applicant]
WO 2013151447A1
· 2013
[cited by applicant]
WO 2013163687A1
· 2013
[cited by applicant]
WO 2014007655A2
· 2014
[cited by applicant]
WO WO2014025266
· 2014
[cited by applicant]
WO WO2014053010A1
· 2014
[cited by applicant]
WO WO2014138804A1
· 2014
[cited by applicant]
WO 2014205513A1
· 2014
[cited by applicant]
WO 2015008013A1
· 2015
[cited by applicant]
Notice of Reasons for Rejection dated Jan. 20, 2020 issued in Japanese Application No. 2019-010135 with English translation (16 pages).
[cited by applicant]
Notification of the First Office Action dated Jul. 3, 2020 issued in Chinese Application No. 2018108462971 with English translation (19 pages).
[cited by applicant]
First Examination Report dated Aug. 27, 2020 issued in New Zealand Application No. 766847 (3 pages).
[cited by applicant]
First Examination Report dated Sep. 21, 2020 issued in New Zealand Application No. 760188 (7 pages).
[cited by applicant]
First Examination Report dated Sep. 21, 2020 issued in New Zealand Application No. 760191 (3 pages).
[cited by applicant]
First Examination Report dated Sep. 18, 2020 issued in New Zealand Application No. 760194 (4 pages).
[cited by applicant]
First Examination Report dated Sep. 18, 2020 issued in New Zealand Application No. 760195 (4 pages).
[cited by applicant]
First Examination Report dated Sep. 18, 2020 issued in New Zealand Application No. 760196 (4 pages).
[cited by applicant]
Extended European Search Report dated Aug. 6, 2019 issued in European Application No. 19157258.5 (25 pages).
[cited by applicant]
First Office Action issued in related Japanese Application No. 2016-540619, dated Oct. 29, 2018, with English translation, (13 pages).
[cited by applicant]
First Office Action issued in related Taiwanese Application No. 1031440004 dated Nov. 8, 2018, with English translation, (11 pages).
[cited by applicant]
First Examination Report issued in New Zealand Application No. 749247 dated Jan. 18, 2019 (2 pages).
[cited by applicant]
Notice of Opposition to Grant of Patent (Section 21) filed Jun. 27, 2016 by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (2 pages).
[cited by applicant]
Statement of Case dated Aug. 26, 2016 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (9 pages).
[cited by applicant]
Amended Notice of Opposition to Grant of Patent (Section 21), with no markups, dated Aug. 26, 2016, filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (2 pages).
[cited by applicant]
Amended Notice of Opposition to Grant of Patent (Section 21), with markups, dated Aug. 26, 2016, filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (2 pages).
[cited by applicant]
Dolan, Brian, “Philips Respironics offers SleepMapper app to motivate, inform sleep apnea patients”, Mobihealthnews, Apr. 25, 2013, (1 page).
[cited by applicant]
HomeCare Magazine, “Connectivity Drives Compliance”, Apr. 28, 2016, http://www.homecaremag.com/hmeproducts/connectivitydrivescompliance (8 pages).
[cited by applicant]
Second Amended Notice of Opposition to Grant of Patent (Section 21), with no markups, dated Nov. 22, 2016, filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (2 pages).
[cited by applicant]
Second Amended Notice of Opposition to Grant of Patent (Section 21), with markups, dated Nov. 22, 2016, filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (2 pages).
[cited by applicant]
Amended Statement of Case, with no markups, dated Nov. 21, 2016 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (10 pages).
[cited by applicant]
Amended Statement of Case, with markups, dated Nov. 21, 2016 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (11 pages).
[cited by applicant]
Second Amended Statement of Case, with no markups, dated Jan. 25, 2017 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (11 pages).
[cited by applicant]
Second Amended Statement of Case, with markups, dated Jan. 25, 2017 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (10 pages).
[cited by applicant]
Third Amended Notice of Opposition to Grant of Patent (Section 21), with no markups, filed Feb. 7, 2018 by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (2 pages).
[cited by applicant]
Third Amended Notice of Opposition to Grant of Patent (Section 21). with markups, filed Feb. 7, 2018 by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (2 pages).
[cited by applicant]
Third Amended Statement of Case, with no markups, dated Feb. 7, 2018 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (13 pages).
[cited by applicant]
Third Amended Statement of Case, with markups, dated Feb. 7, 2018 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 630762 (13 pages).
[cited by applicant]
Xu, Lie Jie, and Guo, Yong-Xin, “Dual-Band Implantable Antenna with Open-End Slots on Ground”, IEEE Antennas and Wireless Propagation Letters, vol. 11, 2012, pp. 1564-1567 (4 pages).
[cited by applicant]
First Office Action issued in Taiwanese Application No. 103121801 dated Jun. 20, 2018 with English translation (7 pages).
[cited by applicant]
Extended European Search Report issued in European Application No. 18 16 7630.5 dated Jun. 20, 2018, (10 pages).
[cited by applicant]
First Office Action issued in related Japanese Application No. 2016-522136 dated May 14, 2018, with English translation, 8 pages.
[cited by applicant]
First Office Action issued in Chinese Application No. 201480075670.8 dated Mar. 19, 2018, with English translation, 11 pages.
[cited by applicant]
European Search Report issued in related European Application No. 14871575.8-1664, dated Sep. 20, 2017, (16 pages).
[cited by applicant]
Kin-Lu Wong, “
[cited by applicant]
First Office Action issued in related Chinese Application No. 2014800469563.3 with English translation, dated Mar. 28, 2017, 15 pages.
[cited by applicant]
Extended Search Report issued in related European Application No. 14818607.5, dated Nov. 15, 2016, 8 pages.
[cited by applicant]
International Preliminary Report on Patentability for PCT/AU2014/050426 mailed Jun. 16, 2016, 8 pages.
[cited by applicant]
International Search Report for PCT/AU2014/050089, mailed Oct. 1, 2014, 12 pages.
[cited by applicant]
Written Opinion of the ISA for PCT/AU2014/050089, mailed May 28, 2015, 6 pages.
[cited by applicant]
Written Opinion of the ISA for PCT/AU2014/050089, mailed Oct. 1, 2014, 7 pages.
[cited by applicant]
International Preliminary Report on Patentability for PCT/AU2014/050089, Jun. 15, 2015, 50 pages.
[cited by applicant]
West, “Respiratory Physiology”, Lippincott Williams & Wilkins, 9th edition published 2011, 8 pages.
[cited by applicant]
“BalContact Springs Current Carrying Contact Elements DM-7, BalContact Advantages”, Bal Seal Canted Coil Spring Catalog, Report No. 621-9, 2003, Bal Seal Engineering Company, Inc., 27 pages.
[cited by applicant]
Patent Examination Report No. 1 issued in related Australian Application No. 2014301955, dated Feb. 16, 2016, 2 pages.
[cited by applicant]
First Examination Report issued in related New Zealand Application No. 631008, dated Feb. 18, 2016, 2 pages.
[cited by applicant]
Written Opinion for PCT/AU2014/050426 mailed Mar. 16, 2015, 7 pages.
[cited by applicant]
International Search Report for PCT/AU2014/050426 mailed Mar. 16, 2015, 8 pages.
[cited by applicant]
First Examination Report dated Sep. 25, 2020 issued in New Zealand Application No. 760189 (4 pages).
[cited by applicant]
First Examination Report dated Oct. 14, 2020 issued in New Zealand Application No. 760190 (5 pages).
[cited by applicant]
First Examination Report dated Sep. 25, 2020 issued in New Zealand Application No. 760192 (4 pages).
[cited by applicant]
First Examination Report dated Sep. 25, 2020 issued in New Zealand Application No. 760193 (4 pages).
[cited by applicant]
Office Action dated Nov. 19, 2020 issued in U.S. Appl. No. 17/007,798 (15 pages).
[cited by applicant]
Final Rejection dated Nove. 30, 2020 issued in Japanese Application No. 2019-010135 with English translation (10 pages).
[cited by applicant]
First Examination Report dated Nov. 19, 2020 issued in New Zealand Application No. 760134 (5 pages).
[cited by applicant]
Certified Priority Document AU Application No. 2013900901 filed Mar. 15, 2013 (78 pages).
[cited by applicant]
Certified Priority Document AU Application No. 2013901965 filed May 31, 2013 (84 pages).
[cited by applicant]
Second Examination Report dated Dec. 24, 2020 issued in New Zealand Application No. 760194 (4 pages).
[cited by applicant]
Second Examination Report dated Dec. 23, 2020 issued in New Zealand Application No. 760195 (4 pages).
[cited by applicant]
Second Examination Report dated Dec. 23, 2020 issued in New Zealand Application No. 760196 (4 pages).
[cited by applicant]
Second Examination Report dated Jan. 22, 2021 issued in New Zealand Application No. 760189 (3 pages).
[cited by applicant]
Office Action dated Feb. 22, 2021 issued in Chinese Application No. 201810846297.1 with English translation (11 pages).
[cited by applicant]
Second Examination Report dated Feb. 24, 2021 issued in New Zealand Application No. 751047 (3 pages).
[cited by applicant]
John Crane Type 6 Elastomer Bellows Seal, https://web.archiveorg/web/20091229113803/http:/www.allsealsinc.c0m/johncrane/type6j0hncrane.pdf, captured Dec. 29, 2009, (4 pages).
[cited by applicant]
ResMed S7™ Lightweight Patient Information Brochure, 2003, 2 pages.
[cited by applicant]
ResMed S7™ Lightweight User's Manual, 2006, 33 pages.
[cited by applicant]
Office Action under Ex Parte Quayle dated Jan. 24, 2022 issued in U.S. Appl. No. 17/488,780 (17 pages).
[cited by applicant]
Notice of Allowance dated Mar. 30, 2022 issued in U.S. Appl. No. 17/488,780 (7 pages).
[cited by applicant]
Office Action dated Mar. 25, 2022 issued in U.S. Appl. No. 17/550,699 (15 pages).
[cited by applicant]
First Examination Report dated Feb. 24, 2022 issued in New Zealand Application No. 784832 (2 pages).
[cited by applicant]
Communication dated Mar. 3, 2022 issued in European Application No. 19157258.5 (8 pages).
[cited by applicant]
Office Action dated Aug. 30, 2021 issued in Japanese Application No. 2020-248165 with English translation (9 pages).
[cited by applicant]
Notification of Grant dated Sep. 1, 2021 issued in Chinese Application No. 201810846297.1 (6 pages).
[cited by applicant]
Office Action dated Oct. 11, 2021 issued in Japanese Application No. 2021-057300 with English translation (13 pages).
[cited by applicant]
Notice of Allowance dated Jan. 24, 2022 issued in Japanese Application No. 2021-057300 (3 pages).
[cited by applicant]
Deadline for Counterstatement dated Dec. 2, 2021 issued in New Zealand Application No. 751047 (1 page).
[cited by applicant]
Notice of Opposition to Grant of Patent dated Nov. 30, 2021 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 751047 (3 pages).
[cited by applicant]
Statement of Case dated Nov. 30, 2021 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 751047 (22 pages).
[cited by applicant]
ResMed, Elisée™ 150 Clinical Manual, English, N0T013189-6 Jul. 11, 2007 (176 pages).
[cited by applicant]
Extended European Search Report dated Jan. 2, 2023 issued in European Application No. 22194862.3 (27 pages).
[cited by applicant]
Extended European Search Report dated Dec. 23, 2022 issued in European Application No. 22194811.0 (20 pages).
[cited by applicant]
Office Action dated Jan. 4, 2023 issued in Japanese Application No. 2022-025696 with English translation (15 pages).
[cited by applicant]
Office Action dated Jan. 12, 2023 issued in Chinese Application No. 202111353218.1 with English translation (14 pages).
[cited by applicant]
Extended European Search Report dated Mar. 20, 2023 issued in European Application No. 22206874.4 (20 pages).
[cited by applicant]
Extended European Search Report dated Mar. 30, 2023 issued in European Application No. 22206389.3 (15 pages).
[cited by applicant]
Extended European Search Report dated Apr. 13, 2023 issued in European Application No. 22206804.1 (25 pages).
[cited by applicant]
Extended European Search Report dated Apr. 14, 2023 issued in European Application No. 22214398.4 (25 pages).
[cited by applicant]
Notice of Allowance dated Jun. 12, 2023 issued in Japanese Application No. 2022-025696 (3 pages).
[cited by applicant]
Office Action dated Oct. 28, 2023 issued in Chinese Application No. 202111353217.7 with English translation (18 pages).
[cited by applicant]
First Examination Report dated Aug. 7, 2023 issued in New Zealand Application No. 801986 (1 page).
[cited by applicant]
Office Action dated Mar. 11, 2024 issued in Chinese Application No. 202011564901.5 with English translation (24 pages).
[cited by applicant]
Office Action dated Mar. 18, 2024 issued in Chinese Application No. 202111353251.4 with English translation (12 pages).
[cited by applicant]
Office Action dated Mar. 23, 2024 issued in Chinese Application No. 202111346419.9 with English translation (18 pages).
[cited by applicant]
Office Action dated Mar. 26, 2024 issued in Chinese Application No. 202111352825.6 with English translation (22 pages).
[cited by applicant]
Office Action dated Apr. 11, 2024 issued in Chinese Application No. 202111352831.1 with English translation (15 pages).
[cited by applicant]
Communication Pursuant to Article 94(3) EPC dated May 24, 2024 issued in European Application No. 19157258.5 (8 pages).
[cited by applicant]
Office Action dated May 20, 2024 issued in Chinese Application No. 202111353251.4 with English translation (13 pages).
[cited by applicant]
Notice of Grant dated Jun. 21, 2024 issued in Chinese Application No. 202111346419.9 (5 pages).
[cited by applicant]
Notice of Grant dated Jul. 1, 2024 issued in Chinese Application No. 202111352831.1 (5 pages).
[cited by applicant]
Office Action dated Jun. 19, 2024 issued in Chinese Application No. 202111353217.7 with English translation (19 pages).
[cited by applicant]
Office Action dated Jun. 24, 2024 issued in Chinese Application No. 202111352825.6 with English translation (24 pages).
[cited by applicant]
Office Action dated Jul. 1, 2024 issued in Japanese Application No. 2023-114614 with English translation (10 pages).
[cited by applicant]
Office Action dated Nov. 26, 2024 issued in Chinese Application No. 202011564901.5 with English translation (26 pages).
[cited by applicant]